Long noncoding RNA BDNF-AS is downregulated in cervical cancer and has anti-cancer functions by negatively

Huimin Zhang1, Caihong Liu1, Ting Yan1

  • 1Department of Gynaecology, Guizhou Provincal People's Hospital, Guiyang, Guizhou Province, 550002, China.

Abstract

Insights

Long noncoding RNA BDNF-AS is downregulated in cervical cancer (CC). Overexpressing BDNF-AS inhibits CC cell proliferation and migration, potentially via inverse regulation of BDNF.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical cancer (CC) remains a significant global health challenge.
  • Understanding the molecular mechanisms underlying CC progression is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the expression and functional role of the long noncoding RNA (lncRNA) BDNF-AS in human cervical cancer.
  • To elucidate the mechanism by which BDNF-AS influences CC progression, particularly its relationship with BDNF.

Main Methods:

  • Quantitative real-time PCR (qPCR) was used to assess BDNF-AS and BDNF expression in CC cell lines and tumor tissues.
  • Lentiviral vectors were employed to overexpress BDNF-AS in CC cells (SiHa and DoTc2-4510).
  • In vitro assays evaluated the effects of BDNF-AS overexpression on CC cell proliferation and migration, while in vivo studies assessed tumor transplantation.

Main Results:

  • BDNF expression was found to be downregulated in both CC cell lines and human CC tumors.
  • Overexpression of BDNF-AS demonstrated anti-cancer effects by inhibiting CC cell proliferation and migration in vitro, and reducing tumor growth in vivo.
  • BDNF-AS and BDNF exhibited inverse expression patterns in CC.
  • Restoring BDNF levels in BDNF-AS-overexpressing cells reversed the observed anti-cancer effects.

Conclusions:

  • BDNF-AS is significantly downregulated in cervical cancer.
  • Ectopic expression of BDNF-AS exhibits potent anti-cancer properties in CC, likely through the inverse regulation of BDNF.
  • Targeting BDNF-AS may represent a promising therapeutic avenue for cervical cancer treatment.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.5K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K